Krsnaa Diagnostics enters B2C segment with chain of 600 diagnostic centres

Mainly a PPP and B2B player, the Pune-based chain offers disruptive pricing

Pune headquartered Krsnaa Diagnostics, primarily a public-private partnership (PPP) and business-to-business (B2B) player, is now set to enter the business-to-consumer (B2C) segment with a chain of 600 diagnostic centres across the country. Krsnaa’s entry into the B2C space is likely to change the industry dynamics on pricing, felt analysts.

This is because Krsnaa is known for disruptive pricing – it offers imaging and pathological tests at discounts of 45-60 per cent and 40–80 per cent to the market rates, respectively.

At present, close to 60 per cent of Krsnaa’s revenues come from the PPP segment, and the remaining are from